News Detail
Maryland, 31 Jan 2024: The US Food and Drug Administration (FDA) outlined its thinking on what sponsors should consider when submitting premarket applications for chimeric antigen receptor (CAR) T cell products, including recommendations for its non-clinical, clinical, and manufa......
View Details
Source : Regulatory Focus
US Food and Drug Administration (FDA)
chimeric antigen receptor (CAR) T cell products
CAR T final guidance
Related News
- Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)
- CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)
- India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)
- US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)
- Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)
- DCC recommends making Sugam portal database of all products with brand names (17-09-2024)
- CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)
- One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)
- Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)
- CDSCO to switch Form 44 submission online (16-09-2024)